Sales of 10 largest multinational firms grow 3% in 2011

Published: 2012-04-17 07:00:00

Updated: 2012-04-17 07:00:00

The combined sales of top 10 multinational drug firms in Korea grew a mere three percent on-year in 2011, while their net profit jumped 56.4 percent on average, data showed Monday.

The data compiled by Yakup.com, a pharmaceutical information company, showed that GlaxoSmithKline (GSK) kept its ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK